Detalhe da pesquisa
1.
Bortezomib elevates intracellular free Fe2+ by enhancing NCOA4-mediated ferritinophagy and synergizes with RSL-3 to inhibit multiple myeloma cells.
Ann Hematol
; 2024 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38647678
2.
Diallyl disulfide synergizes with melphalan to increase apoptosis and DNA damage through elevation of reactive oxygen species in multiple myeloma cells.
Ann Hematol
; 103(4): 1293-1303, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38148345
3.
Proline promotes proliferation and drug resistance of multiple myeloma by downregulation of proline dehydrogenase.
Br J Haematol
; 201(4): 704-717, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36755409
4.
NEK2 promotes the progression of liver cancer by resisting the cellular senescence. / NEK2éè¿æµæèçç»èè¡°èä¿è¿èçè¿å±.
Zhong Nan Da Xue Xue Bao Yi Xue Ban
; 47(2): 153-164, 2022 Feb 28.
Artigo
em Inglês, Chinês
| MEDLINE | ID: mdl-35545405
5.
Epigenetic modification and BRAF gene mutation in thyroid carcinoma.
Cancer Cell Int
; 21(1): 687, 2021 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34923978
6.
Lycorine targets multiple myeloma stem cell-like cells by inhibition of Wnt/ß-catenin pathway.
Br J Haematol
; 189(6): 1151-1164, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32167591
7.
Phosphoglycerate dehydrogenase promotes proliferation and bortezomib resistance through increasing reduced glutathione synthesis in multiple myeloma.
Br J Haematol
; 190(1): 52-66, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32037523
8.
High COX-2 expression in cancer-associated fibiroblasts contributes to poor survival and promotes migration and invasiveness in nasopharyngeal carcinoma.
Mol Carcinog
; 59(3): 265-280, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31867776
9.
High NEK2 confers to poor prognosis and contributes to cisplatin-based chemotherapy resistance in nasopharyngeal carcinoma.
J Cell Biochem
; 120(3): 3547-3558, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30295336
10.
RARα2 expression confers myeloma stem cell features.
Blood
; 122(8): 1437-47, 2013 Aug 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-23847194
11.
Aldo-keto reductase 1B10 as a Carcinogenic but Not a Prognostic Factor in Colorectal Cancer.
J Cancer
; 15(6): 1657-1667, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38370384
12.
The intestinal γδ T cells: functions in the gut and in the distant organs.
Front Immunol
; 14: 1206299, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37398661
13.
Phospholipase C delta 1 inhibits WNT/ß-catenin and EGFR-FAK-ERK signaling and is disrupted by promoter CpG methylation in renal cell carcinoma.
Clin Epigenetics
; 15(1): 30, 2023 02 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36849889
14.
Roles of oncogenes in esophageal squamous cell carcinoma and their therapeutic potentials.
Clin Transl Oncol
; 25(3): 578-591, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36315334
15.
Excessive serine from the bone marrow microenvironment impairs megakaryopoiesis and thrombopoiesis in Multiple Myeloma.
Nat Commun
; 14(1): 2093, 2023 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37055385
16.
Anticancer and Anti-Inflammatory Mechanisms of NOSH-Aspirin and Its Biological Effects.
Comput Math Methods Med
; 2022: 4463294, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36035295
17.
Blocking glycine utilization inhibits multiple myeloma progression by disrupting glutathione balance.
Nat Commun
; 13(1): 4007, 2022 07 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35817773
18.
Genetic Aberrations and Interaction of NEK2 and TP53 Accelerate Aggressiveness of Multiple Myeloma.
Adv Sci (Weinh)
; 9(9): e2104491, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35088582
19.
Differentials of SARS-CoV-2 Viral RNA Re-positivity in Discharged COVID-19 Patients.
AIDS Rev
; 23(3): 153-163, 2021 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34082440
20.
Chidamide, a subtype-selective histone deacetylase inhibitor, enhances Bortezomib effects in multiple myeloma therapy.
J Cancer
; 12(20): 6198-6208, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34539893